Skip to content
Multiple Sclerosis News Today logo Newsletter
Newsletter
  • About MS
    Multiple sclerosis overview
    • Types of MS
    • Causes and risk factors
    • Symptoms
    • Diagnosis
    • Living with MS
    Treatments options for MS
    • Approved treatments
    • Experimental treatments
    Clinical Trials
    • What are clinical trials?
    • Types of clinical trials
    • How do clinical trials work?
    • Traditional vs. remote vs. hybrid clinical trials
    • FAQs about clinical trials
  • Featured Topics
    Newly diagnosed guide
    • MS and employment
    • Next steps after an MS diagnosis
    • MS caregivers guide
    • MS healthcare team
    • Perspectives on MS diagnosis
    • MS treatment explainer
    • Questions to ask your doctor
    • Guidelines for MS diagnosis
    • Physical activity and quality of life
    • Foods to eat and avoid
    • View all
    MS pathways
    • MS and sleep
    • Videos: Worth the talk
    • Managing RRMS
    • Changing MS therapy
    • Mental health and MS
    • MS spasticity stretches
    • MS apps and tools
    • Energy levels and MS
    • MS and eating
    Living strong
    • Stress and MS
    • MS and exercise
    • MS safe home tips
    • MS in women
    • Talking to your doctor
    • Recognizing MS symptoms
    • MS and restless leg syndrome
    Resources
    • MS hug
    • MS and heat
    • Cannabis and MS
    • Lesions and MS
    • Myelin's role in MS
    • Epstein-Barr virus and MS
    • Stem cell therapy for MS
    • MS prognosis and life expectancy
    • MS and mental health
    Expert voices
    • Exercise
    • Pain management
    • Cannabis use
    • Diet and nutrition
    • Financial planning
    • Managing fatigue
    • Sleeping well
    • More
  • News
  • Columns
    Authentically Human – Desiree Lama
    Balancing Grit and Grace – Ahna Crum
    Chairborne — Ben Hofmeister
    Delicate Balance – Leigh Anne Nelson
    Rhythms and Routines – Susan Payrovi, MD
    Archived Columns
    • A Life in Letters — Jamie Hughes
    • DISabled to ENabled — Jessie Ace
    • Dive to Fight MS – Mike Parker
    • Fall Down, Get Up Again — John Connor
    • Goldilochs — Stephen De Marzo
    • Patiently Awakened — Teresa Wright-Johnson
    • The MS Wire — Ed Tobias
    • Silver Linings — Jennifer Powell
    In memoriam
    • Through the Looking Glass — Beth Shorthouse-Ullah
  • Forums
  • Video & Podcasts
    Get Tough on Multiple Sclerosis Video Series
    Get Tough on Multiple Sclerosis Podcast
    The Multiple Sclerosis Podcast
  • Advocacy partners
  • MS spotlight
  • What can we help you find today?

April 5, 2022 News by Marta Figueiredo, PhD

#AAN2022 – Long-term Evobrutinib Safe, Effective in Relapsing MS

Long-term treatment with evobrutinib safely and effectively reduces the rate of relapses in adults with relapsing forms of multiple sclerosis (MS), according to 2.5 years of data from a Phase 2 extension study. These findings — supporting evobrutinib’s therapeutic potential in relapsing MS — were shared in an…

December 16, 2021 News by Yedida Y Bogachkov PhD

Management Programs May Help Keep Fatigue Stable Over Long-term

Fatigue management — whether through a symptom-specific self-management program or through general education regarding managing multiple sclerosis (MS) — may help people with MS in keeping fatigue levels stable in the long term, a recent study suggests. Indeed, the benefits of such programs were found to remain in effect…

October 18, 2021 News by Marta Figueiredo, PhD

#ECTRIMS2021 – Early Ocrevus Slows MS Better Versus 2-year Delay

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the conference. Early use of…

July 7, 2020 News by Marta Figueiredo, PhD

Study: Mavenclad Shows Long-term Effectiveness at Preventing MS Relapses, Disease Progression

Mavenclad (cladribine) prevents relapses and disease progression in more than half of patients with relapsing forms of multiple sclerosis (MS) for at least five years after the last dose, according to a real-life study from Italy. These findings, based on real-world data from Italian MS patients previously treated…

January 16, 2018 News by Patricia Inacio, PhD

Long-term Rituxan Treatment Is Effective and Safe in MS, Study Shows

The approved lymphoma therapy Rituxan (rituximab) has shown promise as a treatment for  multiple sclerosis. A new study indicates the Genentech treatment is effective and safe against neurological diseases like MS for up to seven years. The research, “Long-term safety of rituximab induced peripheral B-cell depletion in…

September 19, 2016 News by Patricia Silva, PhD

#ECTRIMS2016 – Treatment of Progressive MS May Have Delayed Result

There might be years-long lags in response to disease-modifying drugs in patients with progressive forms of multiple sclerosis (MS), according to a study that analyzed data from two large clinical trials of progressive MS patients. The study fuels the idea that clinical trials of disease-modifying drugs for progressive MS need…

August 11, 2016 News by Patricia Silva, PhD

Early Disease Activity in MS Seen to Have Little Long-Term, Prognostic Value

A large study of multiple sclerosis patients (MS) came to the conclusion that clinical and brain imaging assessments drawn from magnetic resonance imaging (MRI) scans are poor measures of long-term prognosis for patients. The study, “Long-term evolution of multiple sclerosis disability in the treatment era,” published in the journal…

Recent Posts

  • With multiple sclerosis, it’s OK to rant sometimes
  • Intrathecal methotrexate halts disability worsening, data show
  • Patients with PIRA have more damage to white matter: Study


Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 All rights reserved.